GSDME and non-small cell lung carcinoma: In the context of NSCLC, overexpression of GSDME leads to mitochondrial damage and activates the cGAS-STING-IFNβ signaling pathway, which promotes CD8+ T cell proliferation and results in favorable anti-cancer effects [349] (Table 2).